Literature DB >> 6852912

Lack of antibodies to human heart tissue in sera of rhesus monkeys immunized with Streptococcus mutans antigens and comparative study with rabbit antisera.

L A Bergmeier, T Lehner.   

Abstract

Immunization of rabbits and rhesus monkeys with Streptococcus mutans whole cells, cell walls, and defined streptococcal antigens (SAs) SA I/II, SA I, and SA II resulted in high antibody titers to SA I/II (10(-4) to 10(-6)) when tested by the solid-phase radioimmunoassay. Cross-reactive antibodies to heart homogenates (HH) were not elicited in rhesus monkeys. A few rabbits immunized with cell wall or SA II preparation in Freund complete adjuvant followed by the incomplete adjuvant yielded low antibody titers (up to 10(-2)) to the HH. The specificity of the putative heart cross-reactive antibodies was tested by immunoadsorption with related and unrelated antigens. Whereas antibody to SA I/II showed specific adsorption with SA I/II but not with HH, immunoglobulin G, or the unrelated antigens, antibody to HH seemed to have been adsorbed with all of the related and unrelated antigens. There was no evidence for the development of heart cross-reactive antibodies on immunization of rhesus monkeys or rabbits with SA I/II and aluminium hydroxide or Freund incomplete adjuvant, administered by the subcutaneous or intramuscular route in doses of up to 13 mg of the immunogen.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6852912      PMCID: PMC348160          DOI: 10.1128/iai.40.3.1075-1082.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  Characterisation of antigens extracted from cells and culture fluids of Streptococcus mutans serotype c.

Authors:  M W Russell; T Lehner
Journal:  Arch Oral Biol       Date:  1978       Impact factor: 2.633

Review 3.  Reevaluation of experiments intended to demonstrate immunological cross-reactions between mammalian tissues and streptococci.

Authors:  P Christensen; C Schalén; S E Holm
Journal:  Prog Allergy       Date:  1979

4.  Immunization against dental caries.

Authors:  W H Bowen; B Cohen; M F Cole; G Colman
Journal:  Br Dent J       Date:  1975-07-15       Impact factor: 1.626

5.  Association between HLA-DR antigens and helper cell activity in the control of dental caries.

Authors:  T Lehner; J R Lamb; K L Welsh; R J Batchelor
Journal:  Nature       Date:  1981-08-20       Impact factor: 49.962

6.  A radioimmunoassay for serum and gingival crevicular fluid antibodies to a purified protein of Streptococcus mutans.

Authors:  R Smith; T Lehner
Journal:  Clin Exp Immunol       Date:  1981-02       Impact factor: 4.330

7.  Generation of specfic T-cell suppressor function induced by Streptococcus mutans in monkeys and mice.

Authors:  J R Lamb; S Kontiainen; T Lehner
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

8.  Affinity purification and characterization of protease-susceptible antigen I of Streptococcus mutans.

Authors:  M W Russell; E D Zanders; L A Bergmeier; T Lehner
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

9.  Effects of local immunization with glucosyltransferase on colonization of hamsters by Streptococcus mutans.

Authors:  D J Smith; M A Taubman; J L Ebersole
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

10.  Evidence for an immunological relationship between Streptococcus mutans and human cardiac tissue.

Authors:  M Hughes; S M Machardy; A J Sheppard; N C Woods
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

View more
  9 in total

Review 1.  Recent advances in the development of a Streptococcus mutans vaccine.

Authors:  J P Klein; M Scholler
Journal:  Eur J Epidemiol       Date:  1988-12       Impact factor: 8.082

2.  Immunological cross-reactivity between Streptococcus mutans and human heart tissue examined by cross-immunization experiments.

Authors:  H Y Wu; M W Russell
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

3.  Molecular and immunochemical characterization of recombinant Escherichia coli containing the spaA gene region of Streptococcus sobrinus.

Authors:  J O Ogundipe; R G Holt
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

4.  Local passive immunization by monoclonal antibodies against streptococcal antigen I/II in the prevention of dental caries.

Authors:  T Lehner; J Caldwell; R Smith
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

5.  Surface hydrophobicity, adherence, and aggregation of cell surface protein antigen mutants of Streptococcus mutans serotype c.

Authors:  T Koga; N Okahashi; I Takahashi; T Kanamoto; H Asakawa; M Iwaki
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

6.  Lack of cross-reactivity of antibodies to ribosomal preparations from Streptococcus mutans with human heart and kidney antigens.

Authors:  R L Gregory; I L Shechmeister; J O Brubaker; C T Smedberg; S M Michalek; J R McGhee
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

7.  Anti-IgG antibodies in rheumatic diseases cross-react with Streptococcus mutans SR antigen.

Authors:  F Ackermans; A Pini; D Wachsmann; M Schöller; J Ogier; J P Klein
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

8.  Immunochemistry of the Streptococcus mutans BHT cell membrane: detection of determinants cross-reactive with human heart tissue.

Authors:  G Y Ayakawa; J L Siegel; P J Crowley; A S Bleiweis
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

9.  Characterization of monoclonal antibodies to Streptococcus mutans antigenic determinants I/II, I, II, and III and their serotype specificities.

Authors:  R Smith; T Lehner; P C Beverley
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.